Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Margaux Legrand"'
Autor:
Walter Ferlin, Stéphanie Hugues, Xavier Chauchet, Elise Pernarrieta, Nicolas Bosson, Sébastien Calloud, Louis Hellequin, Margaux Legrand, Alizée Viandier, Françoise Richard, Laura Cons, Pauline Malinge, Tereza Bautzova, Jérémie Bourguignon, Guillemette Pontini, Mengzhu Sun, Ulla Ravn, Valéry Moine, Yves Poitevin, Nicolas Fischer, Limin Shang, Krzysztof Masternak
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/fd883ac37182497abd025cc9848e0fb7
Autor:
Xavier Chauchet, Sebastien Calloud, Margaux Legrand, Laura Cons, Laurence Chatel, Adeline Lesnier, Nicolas Bosson, Pauline Lloveras, Pauline Malinge, Ulla Ravn, Valery Moine, Bruno Daubeuf, Yves Poitevin, Giovanni Magistrelli, Susana Salgado-Pires, Dmitry Shchelokov, Oleg Demin, Limin Shang, Krzysztof Masternak, Walter Ferlin
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c828078209669042ba52d72253b5b501
https://doi.org/10.1136/jitc-2022-sitc2022.0481
https://doi.org/10.1136/jitc-2022-sitc2022.0481
Autor:
Xavier Chauchet, Sebastien Calloud, Pauline LLoveras, Nicolas Bosson, Margaux Legrand, Laurence Chatel, Laura Cons, Adeline Lesnier, Pauline Malinge, Guillemette Pontini, Christophe Guillamo, Dmitry Shchelokov, Oleg Demin, Ulla Ravn, Valéry Moine, Bruno Daubeuf, Giovanni Magistrelli, Yves Poitevin, Susana Salgado-Pires, Limin Shang, Nicolas Fischer, Walter Ferlin, Krzysztof Masternak
Publikováno v:
Cancer Research. 83:2951-2951
To enhance efficacy of anti-PD-1/PD-L1 antibodies, many combinations with various therapeutic agents are being investigated. Blocking the CD47/SIRPα myeloid checkpoint with monoclonal antibodies (mAbs) or decoy receptors is emerging as an effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::723f47e319d77b29f6dfc49746713401
https://doi.org/10.1158/1538-7445.am2023-2951
https://doi.org/10.1158/1538-7445.am2023-2951
Autor:
Xavier Chauchet, Nicolas Bosson, Margaux Legrand, Laura Cons, Sébastien Calloud, Alizée Viandier, Françoise Richard, Pauline Malinge, Tereza Bautzova, Jérémie Bourguignon, Guillemette Pontini, Elise Penarrieta, Mengzhu Sun, Ulla Ravn, Valéry Moine, Giovanni Magistrelli, Yves Poitevin, Stéphanie Hugues, Limin Shang, Walter Ferlin, Krzysztof Masternak
Publikováno v:
Cancer Research. 82:3429-3429
PD-1/PD-L1 blockade has improved survival across many types of cancer, but only in a minority of patients. Co-targeting PD-1/PD-L1 and the CD47/SIRPα myeloid checkpoint with monoclonal antibody (mAb) combinations showed increased antitumor responses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::915418c1526683ccf116b6f0653a576b
https://doi.org/10.1158/1538-7445.am2022-3429
https://doi.org/10.1158/1538-7445.am2022-3429
Autor:
Xavier Chauchet, Sébastien Calloud, Margaux Legrand, Laura Cons, Laurence Chatel, Pauline Lloveras, Coline Burnet-Merlin, Louis Hellequin, Nicolas Bosson, Pauline Malinge, Nicolas Pleche, Jérémie Bourguignon, Guillemette Pontini, Christophe Guillamo, Ulla Ravn, Valéry Moine, Bruno Daubeuf, Yves Poitevin, Giovanni Magistrelli, Limin Shang, Walter Ferlin, Krzysztof Masternak
Publikováno v:
Cancer Research. 82:3428-3428
Blocking the CD47/SIRPα checkpoint has recently emerged as an effective approach to mobilize the myeloid cell compartment and to improve antitumor responses in the clinic. Preclinical models have demonstrated the synergistic benefit of combined CD47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e386a4493f9b75447a37e12584347a0d
https://doi.org/10.1158/1538-7445.am2022-3428
https://doi.org/10.1158/1538-7445.am2022-3428
Autor:
Nicolas Bosson, Margaux Legrand, Ulla Ravn, Stéphanie Hugues, Alizée Viandier, Krzysztof Masternak, Sébastien Calloud, Françoise Richard, Guillemette Pontini, Jérémie Bourguignon, Walter Ferlin, Louis Hellequin, Laura Cons, Xavier Chauchet, Mengzhu Sun, Elise Pernarrieta, Limin Shang, Nicolas Fischer, Valéry Moine, Pauline Malinge, Yves Poitevin, Tereza Bautzova
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPD-1/PD-L1 blockade can significantly improve survival across many types of cancer, but only in a minority of patients. To broaden its therapeutic efficacy, several combination partners are now being evaluated together with PD-1/PD-L1 block
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca904eab9da026f7f6f06302d636c5e2
https://doi.org/10.1136/jitc-2021-sitc2021.265
https://doi.org/10.1136/jitc-2021-sitc2021.265